ArticleCPT: pharmacometrics & systems pharmacology2026
OpenPMX Software for Nonlinear Mixed-Effect Models in Pharmacometrics: Precision Compared With NONMEM First-Order Conditional Estimation.
Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mixed effects models are a backbone of pharmacometrics, and NONMEM software, with the first-order conditional method with interaction having become the de facto industry standard for model estimation. Documentation exists for the general mathematical methodology for estimation, but many technical and implementation details are lacking. OpenPMX aims to enable nonlinear mixed-effects modeling and estimation in a transparent and efficient manner, with open source licensing allowing for broad application and development. Model parameter estimation bias and root mean squared error (RMSE) obtained using OpenPMX were compared to that using NONMEM for five population models and datasets with varying degrees of complexity. For each model and dataset, repeated simulation and estimation were performed, and the per-dataset difference in precision for parameter estimates was calculated for OpenPMX versus NONMEM. We found that the bias and RMSE of OpenPMX are comparable to the industry standard NONMEM, and in some cases slightly better. The project has low complexity, few dependencies, and is open source, with all technical details open for inspection, auditing, and scientific collaboration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.